(0.27%) 5 145.25 points
(0.28%) 38 547 points
(0.38%) 17 914 points
(-0.78%) $83.20
(1.35%) $1.949
(-0.18%) $2 342.90
(1.09%) $27.55
(0.65%) $928.10
(-0.26%) $0.932
(-0.21%) $11.00
(-0.36%) $0.798
(0.87%) $92.67
Live Chart Being Loaded With Signals
Organicell Regenerative Medicine, Inc., a clinical-stage biopharmaceutical company, focuses on the development of biological therapeutics for the treatment of degenerative diseases...
Stats | |
---|---|
本日の出来高 | 4 735.00 |
平均出来高 | 4 716.00 |
時価総額 | 19.97M |
EPS | $-0.00114 ( 2023-07-30 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.567 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-06-29 | Leider Harry L. | Buy | 500 000 | Common Stock |
2023-06-28 | Leider Harry L. | Buy | 549 450 | Common Stock |
2023-12-19 | Leider Harry L. | Sell | 5 248 | Common Stock |
2023-07-07 | Skycrest Holdings, Llc | Buy | 320 710 | Common Stock |
2023-06-29 | Skycrest Holdings, Llc | Buy | 200 000 | Common Stock |
INSIDER POWER |
---|
-77.37 |
Last 93 transactions |
Buy: 116 969 610 | Sell: 385 387 546 |
Organicell Regenerative 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Organicell Regenerative 財務諸表
Annual | 2023 |
収益: | $4.56M |
総利益: | $4.05M (88.86 %) |
EPS: | $-0.990 |
FY | 2023 |
収益: | $4.56M |
総利益: | $4.05M (88.86 %) |
EPS: | $-0.990 |
FY | 2022 |
収益: | $6.49M |
総利益: | $5.74M (88.39 %) |
EPS: | $-1.570 |
FY | 2021 |
収益: | $5.60M |
総利益: | $5.05M (90.21 %) |
EPS: | $-0.0100 |
Financial Reports:
No articles found.
Organicell Regenerative
Organicell Regenerative Medicine, Inc., a clinical-stage biopharmaceutical company, focuses on the development of biological therapeutics for the treatment of degenerative diseases. Its leading product candidate is Zofin, an acellular, biologic therapeutic derived from perinatal sources and is manufactured to retain naturally occurring microRNAs without the addition or combination of any other substance or diluent, which is in Phase I/II clinical trial to treat COVID-19. The company also provides independent education, advertising, and marketing services to medical and other healthcare, anti-aging, and regenerative service providers. It has a research and development agreement with the Centers for Disease Control and Prevention to determine the anti-inflammatory and anti-infective effectiveness of Zofin in experimental models of influenza infection; and an agreement with Oklahoma State University to evaluate Zofin for the treatment of respiratory diseases caused by virus infections of pandemic potential. The company was formerly known as Biotech Products Services and Research, Inc. and changed its name to Organicell Regenerative Medicine, Inc. in June 2018. Organicell Regenerative Medicine, Inc. was incorporated in 2011 and is headquartered in Miami, Florida.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。